is α-synuclein a useful therapeutic target in parkinson's disease?
Published 2 years ago • 160 plays • Length 4:31Download video MP4
Download video MP3
Similar videos
-
2:26
alpha-synuclein as a therapeutic target for parkinson's disease
-
1:21
investigating α-synuclein aggregation as a therapeutic target in parkinson’s disease
-
1:54
targeting α-synuclein as a therapy for parkinson’s disease: strategies in the pipeline
-
1:46
therapeutic approaches to target alpha-synuclein in parkinson’s disease
-
1:26
targeting α-synuclein & neuroinflammation in parkinson's disease
-
14:56
sumoylation on alpha-synuclein as a therapeutic target in parkinson's disease
-
2:02
glycation of α-synuclein in parkinson’s disease
-
1:10
updates on α-synuclein as a biomarker in parkinson's disease
-
2:05
alpha-synuclein inhibitors, kinase inhibitors & targeting mitochondria in parkinson’s disease
-
3:01
the value of alpha-synuclein as a putative target for therapeutic intervention in synucleinopathies
-
1:18:10
alpha-synuclein as a therapeutic target for parkinson’s disease: challenges and opportunities
-
2:49
is clearing α-synuclein enough to treat parkinson’s disease?
-
4:00
peripheral α-synuclein as a parkinson’s disease biomarker
-
1:34
is α-synuclein aggregation a cause or consequence of parkinson’s disease?
-
1:29
prasinezumab: an anti-alpha-synuclein antibody in parkinson's disease
-
1:32
searching for therapeutic targets for parkinson's disease
-
1:00
parkinson’s disease, alpha synuclein, a practical explanation
-
1:09
potential targets for parkinson’s disease treatment
-
1:22
brain region-specific changes in α-synuclein conformations in parkinson’s disease